Skip to main content
. 2016 Nov 15;7(52):86134–86147. doi: 10.18632/oncotarget.13348

Figure 3.

Figure 3

Kaplan–Meier analysis for the influence of Gli1 (A), Foxm1 (B) in overall. survival (OS), and Gli1 (C), Foxm1(D) in progression free survival (PFS) of CRC patients.